Ming-Xia Ye

Papers

Total Citations

H-Index

About

Ming-Xia Ye is a translational cancer researcher whose work focuses on gynecological oncology and preclinical modeling. Her primary research areas include patient-derived tumor xenograft (PDTX) models and the development of personalized therapeutic strategies for gynecological malignancies. Her most notable contribution is the establishment of the PDTX model for gynecological tumors, a breakthrough that enables more accurate drug testing and individualized treatment planning. In her landmark 2019 study, Ye successfully transplanted fresh tumor tissues from 15 patients into immunodeficient NCG mice, demonstrating the feasibility of creating living tumor avatars that preserve the genetic and histological characteristics of the original cancers. This work, which has garnered 16 citations, provides a powerful platform for evaluating chemotherapeutic agents and targeted therapies before patient administration. Ye's research bridges the critical gap between laboratory findings and clinical application, offering new hope for patients with treatment-resistant gynecological cancers. Her dedication to precision oncology continues to influence how researchers approach drug development and personalized medicine in the field of women's cancers.